Inactive Instrument

All News Dynavax Technologies Corporation Nasdaq

Equities

US2681581029

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 01	Dynavax Technologies Corporation Announces Chief Financial Officer Changes	CI
Feb. 23	Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dynavax Technologies : Additional proxy soliciting material – supplement	08:01pm	PU
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024	Apr. 24	PR
Dynavax Technologies Corporation Announces Chief Financial Officer Changes	Apr. 01	CI
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference	Feb. 27	PR
Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue	Feb. 23	MT
Transcript : Dynavax Technologies Corporation, Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Dynavax Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Earnings Flash (DVAX) DYNAVAX TECHNOLOGIES Reports Q4 Revenue $55.6M, vs. Street Est of $52.7M	Feb. 22	MT
Dynavax Technologies Corporation Provides Revenue Guidance for the Year 2024	Feb. 22	CI
Dynavax Technologies Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance	Feb. 22	PR
Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024	Feb. 08	PR
Goldman Sachs Initiates Dynavax Technologies at Neutral Rating With $20 Price Target	Feb. 01	MT
Transcript : Dynavax Technologies Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 11:15 AM	Jan. 11
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights	Jan. 08	PR
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	PR
Dynavax Technologies Corporation(NasdaqGS:DVAX) added to NASDAQ Biotechnology Index	Dec. 18	CI
Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference	Nov. 20	PR
Dynavax Technologies Insider Sold Shares Worth $300,000, According to a Recent SEC Filing	Nov. 07	MT
Dynavax Technologies Insider Sold Shares Worth $282,400, According to a Recent SEC Filing	Nov. 03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Dynavax Technologies Corporation Nasdaq

Equities

US2681581029

All News

Filters